Press Releases

OKLAHOMA CITY, July 25, 2019 /PRNewswire/ -- The Oklahoma Proton Center was named a Top Cancer Center in Oklahoma by Oklahoma Magazine in their annual Best of the Best edition. This is the third time the center has been named a Top Cancer Center by the magazine. Oklahoma Proton Center was acknowledged for providing "highly indiv

Read more...

CUPERTINO, Calif., July 25, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report second quarter and six months ended June 30, 2019 financial results and host a conference call after the market close on Thursday, August 1, 2019.Thur

Read more...

KING OF PRUSSIA, Pa., July 25, 2019 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $238.3 million, or $2.66 per diluted share, during the second quarter of 2019 as compared to $226.1 million, or

Read more...

COLUMBUS, Ga., July 25, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its second quarter results.Total revenues were $5.5 billion during the second quarter of 2019, compared with $5.6 billion in the second quarter of 2018. Net earnings were $817 million

Read more...

SANTA CLARA, Calif., July 25, 2019 /PRNewswire/ --Second Quarter 2019 OverviewRevenue for the second quarter of 2019 was $65.8 million, a 101% increase compared to $32.7 million for the second quarter of 2018. GAAP net loss for the second quarter of 2019 was

Read more...

SAN DIEGO, July 25, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2019, after the market close on Thur

Read more...

TITUSVILLE, N.J., July 25, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive top-line results from the Phase 3 OPTIMUM study, which evaluated the efficacy and safety of ponesimod compared to Aubagio®* (teriflunomide) in adults with relapsing multiple sclerosis. The study met i

Read more...

THOUSAND OAKS, Calif., July 25, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 30, 2019, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:30 p.m. PT

Read more...

SANTA CLARA, Calif., July 25, 2019 /PRNewswire/ -- iFLYTEK, one of the world's leading artificial intelligence (AI) and speech technology companies, is celebrating its inclusion on the 2019 Forbes list of China's "50 Most Innovative Companies."iFLYTEK creates responsible products that improve healthcare and education. MIT Tech

Read more...

MANHASSET, N.Y., July 25, 2019 /PRNewswire/ -- Scientists, journalists and others fascinated by the rapid developments that characterize the emergent field of

Read more...